UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242

Molecular psychiatry, 2017-11, Vol.22 (11), p.1633-1640

2017

Volltextzugriff (PDF)

Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine Therapy

The American journal of psychiatry, 2000-12, Vol.157 (12), p.1973-1979

2000

Volltextzugriff (PDF)

Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy : effects on withdrawal symptoms and taper outcome

Psychopharmacologia, 1999-01, Vol.141 (1), p.1-5

1999

Volltextzugriff (PDF)

An open-label trial of nefazodone in high comorbidity panic disorder

The journal of clinical psychiatry, 1996-06, Vol.57 (6), p.245

1996

Volltextzugriff (PDF)

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

International clinical psychopharmacology, 2001-05, Vol.16 (3), p.137-143

2001

Volltextzugriff (PDF)

Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress

Biological psychiatry (1969), 2001-08, Vol.50 (4), p.254-259

2001

Volltextzugriff (PDF)

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

The journal of clinical psychiatry, 2003-10, Vol.64 (10), p.1224-1229

2003

Volltextzugriff (PDF)

A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder

Journal of clinical psychopharmacology, 2000-02, Vol.20 (1), p.12-18

2000

Volltextzugriff (PDF)

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study

The journal of clinical psychiatry, 2003-07, Vol.64 (7), p.785-792

2003

Volltextzugriff (PDF)

Pharmacologic strategies for discontinuing benzodiazepine treatment

Journal of clinical psychopharmacology, 1999-12, Vol.19 (6 Suppl 2), p.12S-16S

1999

Volltextzugriff (PDF)

Case Report: Marathon runner with severe autonomic failure

The Lancet (British edition), 2005-12, Vol.366, p.S13-S13

2005

Volltextzugriff (PDF)

Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder

The journal of clinical psychiatry, 2000-02, Vol.61 (2), p.91-94

2000

Volltextzugriff (PDF)

P.3.065 Patient-reported functioning in SAD and improvement with treatment: A comparison of venlafaxine XR, paroxetine, and placebo

European neuropsychopharmacology, 2003-10, Vol.13, p.S381-S382

2003

Volltextzugriff (PDF)

Less toxic method for producing giant paper organ sections for pathology and anatomy education

Pathology and laboratory medicine international, 2014-01, Vol.6 (default), p.41-45

2014

Volltextzugriff (PDF)

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

Journal of clinical psychopharmacology, 1997-08, Vol.17 (4), p.272-277

1997

Volltextzugriff (PDF)

Efficacy and tolerability of sertraline in treating anxious depression

European neuropsychopharmacology, 2001, Vol.11, p.S206-S207

2001

Volltextzugriff (PDF)

Results from a randomized, double-blind, multicenter trial of sertaline in the treatment of moderate-to-severe social phobia (social anxiety disorder)

European neuropsychopharmacology, 2002-10, Vol.12, p.352-352

2002

Volltextzugriff (PDF)

Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability

Journal of clinical psychopharmacology, 1998-04, Vol.18 (2), p.145-153

1998

Volltextzugriff (PDF)

A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.318-328

2019

Volltextzugriff (PDF)

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18 F-PF-05270430

Journal of Nuclear Medicine, 2016-09, Vol.57 (9), p.1388-1395

2016

Volltextzugriff (PDF)

First-in-Human Assessment of the Novel PDE2A PET Radiotracer ^sup 18^F-PF-05270430

The Journal of nuclear medicine (1978), 2016-09, Vol.57 (9), p.1388

2016

Volltextzugriff (PDF)

First-in-Human Assessment of the Novel PDE2A PET Radiotracer super( 18)F-PF-05270430

The Journal of nuclear medicine (1978), 2016-09, Vol.57 (9), p.1388-1388

2016

Volltextzugriff (PDF)

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430

The Journal of nuclear medicine (1978), 2016-09, Vol.57 (9), p.1388-1395

2016

Volltextzugriff (PDF)

Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry

British journal of haematology, 1996-06, Vol.93 (4), p.921-927

1996

Volltextzugriff (PDF)

Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry

Journal of clinical pathology, 1996-07, Vol.49 (7), p.539-544

1996

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Female
(16)
Male
(16)
Adult
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Psychiatry
(15)
Pharmacology. Drug Treatments
(11)
Psychology. Psychoanalysis. Psychiatry
(11)
Double-Blind Method
(10)
Neuropharmacology
(10)
Psychopharmacology
(10)
Middle Aged
(8)
Pharmacology & Pharmacy
(7)
Treatment Outcome
(6)
Aged
(5)
Anti-Anxiety Agents - Adverse Effects
(5)
Anti-Anxiety Agents - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242

Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine Therapy

Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy : effects on withdrawal symptoms and taper outcome

An open-label trial of nefazodone in high comorbidity panic disorder

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study

Pharmacologic strategies for discontinuing benzodiazepine treatment

Case Report: Marathon runner with severe autonomic failure

Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder

P.3.065 Patient-reported functioning in SAD and improvement with treatment: A comparison of venlafaxine XR, paroxetine, and placebo

Less toxic method for producing giant paper organ sections for pathology and anatomy education

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

Efficacy and tolerability of sertraline in treating anxious depression

Results from a randomized, double-blind, multicenter trial of sertaline in the treatment of moderate-to-severe social phobia (social anxiety disorder)

Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability

A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18 F-PF-05270430

First-in-Human Assessment of the Novel PDE2A PET Radiotracer ^sup 18^F-PF-05270430

First-in-Human Assessment of the Novel PDE2A PET Radiotracer super( 18)F-PF-05270430

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430

Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry

Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry

Suchergebnisse filtern